Weigao Group
Weigao Group engages in the research and development, production, export, and sale of medical devices.
Launch date
Employees
Market cap
AUD3.7b
Enterprise valuation
AUD3.1b (Public information from Sep 2024)
Share price
HKD4.63 1066.HK
Weihai Shandong (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 11.3b | 13.2b | 13.6b | 13.2b | 13.9b | 15.0b | 16.1b |
| % growth | 9 % | 16 % | 4 % | (3 %) | 5 % | 9 % | 7 % |
| EBITDA | 3.3b | 4.0b | 4.4b | 3.6b | 3.4b | 3.6b | 4.2b |
| % EBITDA margin | 29 % | 31 % | 32 % | 27 % | 25 % | 24 % | 26 % |
| Profit | 2.0b | 2.2b | 2.7b | 2.0b | 2.1b | 2.4b | 2.6b |
| % profit margin | 18 % | 17 % | 20 % | 15 % | 15 % | 16 % | 16 % |
| EV / revenue | 5.7x | 2.5x | 3.6x | 2.1x | 0.9x | 0.8x | 0.6x |
| EV / EBITDA | 19.7x | 8.1x | 11.2x | 7.9x | 3.5x | 3.1x | 2.2x |
| R&D budget | 411m | 492m | 547m | 593m | - | - | - |
| R&D % of revenue | 4 % | 4 % | 4 % | 4 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Weigao Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
